Journal Guide

Translating research into clinical practice.

publishes original research articles, review articles, and clinical studies on all aspects of autoimmunity. Articles focus on the basic biology and mechanism of the disease, and medical treatment of autoimmune diseases.

Current understanding of autoimmune disease is being increasingly underpinned by the new molecular sciences. Progress in this area has been little short of spectacular, and all clinical specialities now recognise autoimmunity as a major component of the diseases with which they are involved. Autoimmunity is an international, peer reviewed journal that publishes articles of clinical and basic science on the pathogenesis, immunology, genetics, molecular biology, and treatment of autoimmune diseases. In addition to the basic mechanisms and elements of the immune system, the journal focuses on the autoimmune processes associated with systemic lupus erythematosus, rheumatoid arthritis, Sjogren syndrome, diabetes, multiple sclerosis, and other systemic and organ-specific autoimmune diseases. The journal is not restricted to any disease type or clinical speciality, but reflects the areas where scientific progress is most rapid and clinical applications significant and widespread. The journal is valuable to clinicians and researchers in immunology and molecular biology. Read More: http://informahealthcare.com/page/aut/Description.

Autoimmunity Reviews will publish up-to-date, structured reviews on diverse topics in autoimmunity, written by first-class experts in the field. The articles will include demonstrative illustrations and tables and will all have a "take-home" message.Articles will principally be invited by the Editors-in-Chief upon the recommendations of the international Editorial Board, and will cover all fields of autoimmunology, bridging the gap between basic and clinical sciences. Contributions in basic sciences will include those on the pathophysiology and mechanisms of disorders as well as genomics and proteomics; clinical contributions will focus upon the diseases, novel therapies and clinical associations.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

2009 Impact Factor: 1.654; Ranked 24/141 (Veterinary Sciences)Increased 2000 Five-Year Impact Factor: 2.217; Ranked 13/141 (Veterinary Sciences) 2009 Article Influence8482; Score: 0.609; Ranked 8/141 (Veterinary Sciences)169; 2010 Thomson Reuters, 2009 Journal Citation ReportsIn February 2009, Thomson Reuters added official Five-Year Impact Factors, Eigenfactors and Article Influence Scores to the 2007 JCR. An explanation of these new metrics can be found at http://science.thomsonreuters.com/press/2009/8499916/ ANNOUNCEMENT: Avian Pathology is ranked number 12 in the top 20 journals most cited within the Thomson Scientific (ISI) Essential Science Indicators Special Topic on Avian Influenza, and the highest ranked journal in the avian sciences!Avian Pathology will consider original material relevant to the entire field of infectious and non-infectious diseases of poultry and all other birds, including infections that may be of zoonotic/food-borne importance. Subject areas include pathology; diagnosis; detection and characterisation of pathogens; gene sequences; epidemiology; immune responses; vaccines; genetics in relation to disease; and physiological and biochemical changes that are in response to disease. Manuscripts reporting cases of naturally occurring disease must describe either new diseases or give significant new information about previously known diseases. The information should significantly enhance knowledge and understanding of the disease or pathogen.Papers on food-borne microorganisms acquired during or after processing are not appropriate. Manuscripts describing the occurrence or morphology of unicellular eukaryotes and multicellular organisms, or which are essentially catalogues of micro-organisms detected, are unlikely to be considered for publication unless they have a clear relationship to disease. First and subsequent reports of occurrence within a country of diseases well-recognized elsewhere will not be accepted unless they also include significant new information about the disease or pathogen. Manuscripts should report novel findings that are of interest to an international readership. DisclaimerThe Houghton Trust Ltd and Taylor & Francis makes every effort to ensure the accuracy of all the information (the 8220;Content8221;) contained in its publications. However, Houghton Trust Ltd and Taylor & Francis and its agents and licensors make no representations or warranties whatsoever as to the accuracy, completeness or suitability for any purpose of the Content and disclaim all such representations and warranties whether expressed or implied to the maximum extent permitted by law. Any views expressed in this publication are the views of the authors and are not the views of the Trust and Taylor & Francis.

BMC Immunology is an open access journal publishing original peer-reviewed research articles in molecular, cellular, tissue-level, organismal, functional, and developmental aspects of the immune system.

BMC Microbiology is an open access journal publishing original peer-reviewed research articles in analytical and functional studies of prokaryotic and eukaryotic microorganisms, viruses and small parasites, as well as host and therapeutic responses to them, and their interaction with the environment.

An essential resource for R&D professionals and clinicians with an interest in biologic therapies.BioDrugs covers the development and use of biotechnology-based pharmaceuticals and innovative technologies for the treatment of human disease.

BioMed Research International (formerly titled Journal of Biomedicine and Biotechnology) is a peer-reviewed, open access journal that publishes original research articles as well as review articles in several areas of life sciences. The subject areas covered by the journal are:BiochemistryBioinformaticsBiophysicsBiotechnologyCell BiologyGeneticsGenomicsImmunologyMicrobiologyMolecular BiologyOncologyPharmacologyToxicologyVirology.

Biocatalysis and Agricultural Biotechnology is the official journal of the International Society of Biocatalysis and Agricultural Biotechnology (ISBAB). The journal publishes high quality articles especially in the science and technology of biocatalysis, bioprocesses, agricultural biotechnology, biomedical biotechnology, and, if appropriate, from other related areas of biotechnology. The journal will publish peer-reviewed basic and applied research papers, authoritative reviews, and feature articles.The scope of the journal encompasses the research, industrial, and commercial aspects of biotechnology, including the areas of: biocatalysis; bioprocesses; food and agriculture; genetic engineering; molecular biology; healthcare and pharmaceuticals; biofuels; genomics; nanotechnology; environment and biodiversity; and bioremediation.Types of papers published are: Full-length original research papers; Short communications; Review articles; Letters to the Editor.

Biodegradation publishes papers, reviews and mini-reviews on the biotransformation, mineralization, detoxification, recycling, amelioration or treatment of chemicals or waste materials by naturally-occurring microbial strains, microbial associations, or recombinant organisms. Coverage spans a range of topics, including Biochemistry of biodegradative pathways; Genetics of biodegradative organisms and development of recombinant biodegrading organisms; Molecular biology-based studies of biodegradative microbial communities; Enhancement of naturally-occurring biodegradative properties and activities. Also featured are novel applications of biodegradation and biotransformation technology, to soil, water, sewage, heavy metals and radionuclides, organohalogens, high-COD wastes, straight-, branched-chain and aromatic hydrocarbons; Coverage extends to design and scale-up of laboratory processes and bioreactor systems. Also offered are papers on economic and legal aspects of biological treatment of waste. 'Waste treatm

2014 Impact Factor: 1.676
©2015 Thomson Reuters, 2015 Journal Citation Reports®  

Aims & Scope:

Bioengineered is a multi-disciplinary, peer reviewed journal dedicated to highlighting the most recent and significant advances in the development of genetically modified organisms for food, pharmaceutical, medical, industrial, environmental and bio-defense applications. With a strong focus on fundamental science, the journal strives to serve a broader readership by regularly publishing articles on regulatory, legal, and political issues related to all aspects of bioengineering and biotechnology.

Bioengineered publishes relevant and timely original research, authoritative overviews, protocols, as well as article addenda and commentaries; providing context for original work presented in Bioengineered and key results published elsewhere. Original research papers may cover any aspect of genetic engineering/biotechnology which involves the generation of recombinant strains (both prokaryote and eukaryote) for beneficial applications in food, medicine, industry, environment and bio-defense.


Relevant topics include (but are not limited to):

• Biomaterials
• Biomolecules
• Molecular Engineering
• Cellular Engineering
• Tissue Engineering
• Bioengineered Therapeutics, Devices and Drug Delivery
• Systems and Synthetic Bioengineering
• Theoretical and Computational Bioengineering
• Bioengery and Biofuels
• Biodefense

All submitted manuscripts are subjected to initial evaluation by the editorial staff, and, if found suitable for further consideration, manuscripts are sent to peer review by independent, anonymous expert referees. All peer review is single blind. Submission is online at http://bioe.msubmit.net/cgi-bin/main.plex
Questions regarding the scope of the journal may be directed to the Editor-in-Chief at roy.sleator@cit.ie. 

Biofouling is an international, peer-reviewed, multi-discliplinary journal which publishes original articles and mini-reviews and provides a forum for publication of pure and applied work on protein, microbial, fungal, plant and animal fouling and its control, as well as studies of all kinds on biofilms and bioadhesion. Papers may be based on studies relating to characterisation, attachment, growth and control on any natural (living) or man-made surface in the freshwater, marine or aerial environments, including fouling, biofilms and bioadhesion in the medical, dental, and industrial context. Specific areas of interest include antifouling technologies and coatings including transmission of invasive species, antimicrobial agents, biological interfaces, biomaterials, microbiologically influenced corrosion, membrane biofouling, food industry biofilms, biofilm based diseases and indwelling biomedical devices as substrata for fouling and biofilm growth. Rapid Online Publication Biofouling now offers even faster publication for its authors. With our Build Issue service, we aim to publish articles within three weeks of receiving the accepted paper*. Articles are entered straight into the online issue upon receipt of the corrected proofs and thereby receiving page numbers immediately. we anticipate that this rapid production service will allow top end research to reach its audiences even sooner , without compromising the peer-review process and whilst continuing to ensure our commitment to publishing research of the highest quality. *This process relies heavily on the immediate return of the copyright form and the return of author corrections within 48hrs of receipt. Peer Review All articles published in this journal have undergone rigorous peer review, based on initial editor screening and anonymous refereeing by independent expert referees. Disclaimer for Scientific, Technical and Social Science Publications Taylor & Francis make every effort to ensure the accuracy of all the information (the 'Content') contained in its publications. However, Taylor & Francis and its agents and licensors make no representations or warranties whatsoever as to the accuracy, completeness or suitability for any purpose of the Content and disclaim all such representations and warranties whether express or implied to the maximum extent permitted by law. Any views expressed in this publication are the views of the authors and are not the views of Taylor & Francis.